Open Demat
Be a Partner
Samadhan
Install App
Install App

13517

531162

EMAMILTD

img img img img
Compare to down-arrow
View down-arrow
Display down-arrow
Studies down-arrow
No Data Available

Emami Share Price Update

As of the latest trading session, Emami share price is currently at ₹416.85, which is down by ₹-1.69 from its previous closing. Today, the stock has fluctuated between ₹412.90 and ₹422.05. Over the past year, Emami has achieved a return of -22.41%. In the last month alone, the return has been -13.11%.

Emami performance

Today’s low

Today’s high

₹ 412.90 ₹ 422.05
₹ 418.55

52 week low

52 week high

₹ 405.05 ₹ 653.35
₹ 418.55

Open Price

₹ 420.40

Prev. Close

₹ 418.55

Volume (Shares)

1001023.00

Total traded value

₹ 4189.78

Upper Circuit

₹ 502.25

Lower Circuit

₹ 334.85

info

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Emami fundamentals


  • Market cap (Cr)

    18,269.70

  • P/E Ratio (TTM)

    21.39

  • Beta

    0.59

  • Book Value / share

    71.79

  • Return on equity

    32.73%

  • EPS (TTM)

    20.03

  • Dividend yield

    2.36%

  • Net profit/quarter (Cr)

    329.80

info icon alternate text

  • Market cap (Cr)

    18,289.30

  • P/E Ratio (TTM)

    21.39

  • Beta

    0.58

  • Book Value / share

    71.79

  • Return on equity

    32.73%

  • EPS (TTM)

    20.03

  • Dividend yield

    2.36%

  • Net profit/quarter (Cr)

    329.80

info icon alternate text

Emami Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2025 (Values in Cr)
Revenue 957.72
Operating Expense 613.00
Net Profit 329.80
Net Profit Margin (%) 34.43
Earnings Per Share (EPS) 7.56
EBITDA 394.36
Effective Tax Rate (%) 6.77
Particulars SEP 2025 (Values in Cr)
Revenue 604.47
Operating Expense 477.47
Net Profit 182.34
Net Profit Margin (%) 30.16
Earnings Per Share (EPS) 4.17
EBITDA 221.47
Effective Tax Rate (%) -0.82
Particulars JUN 2025 (Values in Cr)
Revenue 756.46
Operating Expense 595.84
Net Profit 163.09
Net Profit Margin (%) 21.55
Earnings Per Share (EPS) 3.74
EBITDA 221.48
Effective Tax Rate (%) 10.15
Particulars MAR 2025 (Values in Cr)
Revenue 780.60
Operating Expense 629.83
Net Profit 189.73
Net Profit Margin (%) 24.30
Earnings Per Share (EPS) 4.35
EBITDA 257.25
Effective Tax Rate (%) 12.65
Particulars DEC 2024 (Values in Cr)
Revenue 878.64
Operating Expense 590.61
Net Profit 279.41
Net Profit Margin (%) 31.80
Earnings Per Share (EPS) 6.40
EBITDA 338.30
Effective Tax Rate (%) 6.19
Particulars MAR 2025 (Values in Cr)
Revenue 3123.55
Operating Expense 2346.75
Net Profit 859.22
Net Profit Margin (%) 27.50
Earnings Per Share (EPS) 19.68
EBITDA 1094.72
Effective Tax Rate (%) 8.03
Particulars MAR 2024 (Values in Cr)
Revenue 2921.57
Operating Expense 2238.27
Net Profit 693.39
Net Profit Margin (%) 23.73
Earnings Per Share (EPS) 15.86
EBITDA 915.32
Effective Tax Rate (%) 7.13
Particulars MAR 2023 (Values in Cr)
Revenue 2906.83
Operating Expense 2348.50
Net Profit 573.50
Net Profit Margin (%) 19.72
Earnings Per Share (EPS) 13.00
EBITDA 825.44
Effective Tax Rate (%) 5.41
Particulars MAR 2022 (Values in Cr)
Revenue 2866.87
Operating Expense 2300.75
Net Profit 850.68
Net Profit Margin (%) 29.67
Earnings Per Share (EPS) 19.15
EBITDA 1020.12
Effective Tax Rate (%) -23.45
Particulars MAR 2021 (Values in Cr)
Revenue 2582.28
Operating Expense 2112.11
Net Profit 475.13
Net Profit Margin (%) 18.39
Earnings Per Share (EPS) 10.68
EBITDA 947.37
Effective Tax Rate (%) 17.25
Particulars MAR 2025 (Values in Cr)
Book Value / Share 61.74
ROE % 31.23
ROCE % 33.47
Total Debt to Total Equity 0.04
EBITDA Margin 28.39
Particulars MAR 2024 (Values in Cr)
Book Value / Share 56.05
ROE % 30.49
ROCE % 31.90
Total Debt to Total Equity 0.04
EBITDA Margin 27.58
Particulars MAR 2023 (Values in Cr)
Book Value / Share 52.20
ROE % 28.65
ROCE % 27.90
Total Debt to Total Equity 0.08
EBITDA Margin 27.14
Particulars MAR 2022 (Values in Cr)
Book Value / Share 47.07
ROE % 43.59
ROCE % 32.08
Total Debt to Total Equity 0.10
EBITDA Margin 32.20
Particulars MAR 2021 (Values in Cr)
Book Value / Share 39.65
ROE % 25.36
ROCE % 29.06
Total Debt to Total Equity 0.09
EBITDA Margin 32.95
Particulars MAR 2025 (Values in Cr)
Book Value / Share 65.69
ROE % 32.73
ROCE % 35.01
Total Debt to Total Equity 0.01
EBITDA Margin 35.05
Particulars MAR 2024 (Values in Cr)
Book Value / Share 54.59
ROE % 29.84
ROCE % 31.42
Total Debt to Total Equity 0.01
EBITDA Margin 31.33
Particulars MAR 2023 (Values in Cr)
Book Value / Share 51.31
ROE % 26.37
ROCE % 26.05
Total Debt to Total Equity 0.06
EBITDA Margin 28.40
Particulars MAR 2022 (Values in Cr)
Book Value / Share 47.28
ROE % 44.25
ROCE % 32.92
Total Debt to Total Equity 0.07
EBITDA Margin 35.58
Particulars MAR 2021 (Values in Cr)
Book Value / Share 39.58
ROE % 26.68
ROCE % 30.34
Total Debt to Total Equity 0.06
EBITDA Margin 36.69
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 272.90
Total Assets 3533.62
Total Liabilities 3533.62
Total Equity 2693.35
Share Outstanding 43
Price to Book Ratio 8.82
Return on Assets (%) 22.82
Return on Capital (%) 29.27
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 201.38
Total Assets 3279.70
Total Liabilities 3279.70
Total Equity 2457.71
Share Outstanding 43
Price to Book Ratio 7.86
Return on Assets (%) 22.06
Return on Capital (%) 28.67
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 184.74
Total Assets 3109.85
Total Liabilities 3109.85
Total Equity 2312.76
Share Outstanding 44
Price to Book Ratio 6.98
Return on Assets (%) 20.56
Return on Capital (%) 26.8
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 116.00
Total Assets 3057.48
Total Liabilities 3057.48
Total Equity 2074.29
Share Outstanding 44
Price to Book Ratio 9.47
Return on Assets (%) 27.44
Return on Capital (%) 35.88
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 360.37
Total Assets 2519.68
Total Liabilities 2519.68
Total Equity 1761.76
Share Outstanding 44
Price to Book Ratio 12.32
Return on Assets (%) 18.04
Return on Capital (%) 24.53
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 181.58
Total Assets 3384.02
Total Liabilities 3384.02
Total Equity 2867.15
Share Outstanding 43
Price to Book Ratio 8.82
Return on Assets (%) 25.38
Return on Capital (%) 29.96
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 91.14
Total Assets 2846.66
Total Liabilities 2846.66
Total Equity 2382.97
Share Outstanding 43
Price to Book Ratio 7.86
Return on Assets (%) 24.35
Return on Capital (%) 29.01
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 95.79
Total Assets 2751.37
Total Liabilities 2751.37
Total Equity 2263.69
Share Outstanding 44
Price to Book Ratio 6.98
Return on Assets (%) 20.84
Return on Capital (%) 25.22
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 55.60
Total Assets 2825.88
Total Liabilities 2825.88
Total Equity 2085.95
Share Outstanding 44
Price to Book Ratio 9.47
Return on Assets (%) 30.10
Return on Capital (%) 37.01
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 307.92
Total Assets 2304.09
Total Liabilities 2304.09
Total Equity 1759.32
Share Outstanding 44
Price to Book Ratio 12.32
Return on Assets (%) 20.62
Return on Capital (%) 26.31
Particulars MAR 2025 (Values in Cr)
Net Income 893.86
Cash from Operations 1080.66
Cash from Investing -340.14
Cash from Financing -499.60
Net change in Cash 51.67
Free Cash Flow 1125.23
Particulars MAR 2024 (Values in Cr)
Net Income 790.83
Cash from Operations 925.29
Cash from Investing -205.39
Cash from Financing -562.96
Net change in Cash 6.16
Free Cash Flow 965.88
Particulars MAR 2023 (Values in Cr)
Net Income 669.54
Cash from Operations 865.91
Cash from Investing -112.82
Cash from Financing -607.64
Net change in Cash 16.10
Free Cash Flow 906.37
Particulars MAR 2022 (Values in Cr)
Net Income 688.00
Cash from Operations 786.44
Cash from Investing -234.90
Cash from Financing -402.13
Net change in Cash 7.69
Free Cash Flow 1270.01
Particulars MAR 2021 (Values in Cr)
Net Income 568.92
Cash from Operations 1007.99
Cash from Investing -226.94
Cash from Financing -688.17
Net change in Cash 8.97
Free Cash Flow 1041.68
Particulars MAR 2025 (Values in Cr)
Net Income 934.21
Cash from Operations 1031.12
Cash from Investing -464.76
Cash from Financing -367.87
Net change in Cash 30.93
Free Cash Flow 1071.76
Particulars MAR 2024 (Values in Cr)
Net Income 746.64
Cash from Operations 870.55
Cash from Investing -192.28
Cash from Financing -546.11
Net change in Cash 1.39
Free Cash Flow 901.98
Particulars MAR 2023 (Values in Cr)
Net Income 606.32
Cash from Operations 838.94
Cash from Investing -105.58
Cash from Financing -612.17
Net change in Cash 13.19
Free Cash Flow 870.77
Particulars MAR 2022 (Values in Cr)
Net Income 689.06
Cash from Operations 725.99
Cash from Investing -187.90
Cash from Financing -398.06
Net change in Cash 9.88
Free Cash Flow 1203.35
Particulars MAR 2021 (Values in Cr)
Net Income 574.21
Cash from Operations 944.43
Cash from Investing -199.95
Cash from Financing -678.76
Net change in Cash -0.32
Free Cash Flow 977.36
Company Name Price P/E P/B Market Cap 52 Week Low/High
BRITANNIA INDUSTRIES LTD 5840.65 58.25 37.68 140682.74 4525.05 / 6336.95
NESTLE INDIA LTD. 1211.80 74.76 52.69 233673.13 1075.00 / 1339.85
FOODS & INNS LTD. 53.90 12.74 0.72 396.34 50.00 / 128.79
HINDUSTAN UNILEVER LTD. 2174.45 46.80 10.48 510906.87 2105.10 / 2734.31
Company Name Price P/E P/B Market Cap 52 Week Low/High
BRITANNIA INDUSTRIES LTD 5840.65 57.82 43.04 140682.74 4525.05 / 6336.95
COLGATE PALMOLIVE LTD. 1939.95 39.57 33.34 52763.85 1920.00 / 2745.95
NESTLE INDIA LTD. 1211.80 73.49 51.19 233673.13 1075.00 / 1339.85
FOODS & INNS LTD. 53.90 11.25 0.72 396.34 50.00 / 128.79

Emami shareholding pattern

Holding

9.39%
54.84%
9.03%
26.72%
11.6%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

Emami Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
418.55 -1.30 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 429.70
  • 26 Days 462.60
  • 10 Days 440.90
  • 50 Days 480.00
  • 12 Days 444.70
  • 100 Days 502.80
  • 20 Days 456.30
  • 200 Days 532.40
419.05 PIVOT

First Support

410.10

First Resistance

433.05

Second Support

396.10

Second Resistance

442.00

Third Support

387.15

Third Resistance

456.00

RSI

28.21

ADX

63.52

MACD

-17.89

Williams % R

-75.21

Commodity Channel Index (CCI)

-150.55

Date

2026-03-16

Week

298357.00

Same Day

288162.00

Month

243119.00

1 Year

0.60

3 Year

0.65

Over 1 Month

-13.11%

down

Over 1 Year

-22.41%

down

Over 3 Months

-21.80%

down

Over 3 Years

5.81%

down

Over 6 Months

-29.68%

down

Over 5 Years

-2.78%

down

Emami Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
10 Feb 2026 6.0 Interim 2 10 Feb 2026 Equity shares
14 Nov 2025 4.0 Interim 1 14 Nov 2025 Equity shares
22 May 2025 2.0 Special 22 May 2025 Equity shares
04 Feb 2025 4.0 Interim 2 04 Feb 2025 Equity shares
18 Nov 2024 4.0 Interim 1 18 Nov 2024 Equity shares
16 Feb 2024 4.0 Interim 2 19 Feb 2024 Equity shares
15 Nov 2023 4.0 Interim 1 15 Nov 2023 Equity shares
13 Feb 2023 4.0 Interim 2 13 Feb 2023 Equity shares
18 Nov 2022 4.0 Interim 21 Nov 2022 Equity shares
10 Feb 2022 4.0 Interim 2 11 Feb 2022 Equity shares
08 Nov 2021 4.0 Interim 09 Nov 2021 Equity shares
04 Feb 2021 4.0 Interim 2 05 Feb 2021 Equity shares
12 Nov 2020 4.0 Interim 13 Nov 2020 Equity shares
26 Mar 2020 2.0 Interim 2 27 Mar 2020 Equity shares
14 Nov 2019 2.0 Interim 15 Nov 2019 Equity shares
31 Jul 2019 4.0 Final 02 Aug 2019 Equity shares
21 Jun 2018 7.0 Final 22 Jun 2018 Equity shares
26 Jul 2017 5.25 Final 28 Jul 2017 Equity shares
14 Mar 2017 1.75 Interim 15 Mar 2017 Equity shares
26 Jul 2016 7.0 Final 28 Jul 2016 Equity shares
28 Jul 2015 3.0 Final 30 Jul 2015 Equity shares
01 Aug 2014 4.0 Interim 22 Sep 2014 Equity shares
01 Aug 2014 4.0 Final 05 Aug 2014 Equity shares
24 Jan 2014 3.0 Interim 27 Jan 2014 Equity shares
26 Jun 2013 8.0 Final 27 Jun 2013 Equity shares
02 Aug 2012 4.0 Special 04 Aug 2012 Equity shares
02 Aug 2012 4.0 Final 04 Aug 2012 Equity shares
05 Aug 2011 3.5 Final 09 Aug 2011 Equity shares
21 Jul 2010 3.0 Final 23 Jul 2010 Equity shares
22 Dec 2009 4.5 Final 24 Dec 2009 Equity shares
18 Aug 2008 4.5 Final 21 Aug 2008 Equity shares
20 Sep 2007 1.0 Final 22 Sep 2007 Equity shares
22 Mar 2007 1.0 Special 23 Mar 2007 Equity shares
22 Mar 2007 2.0 Interim 23 Mar 2007 Equity shares
18 Aug 2005 0.0 Final 20 Aug 2005 Equity shares
Ex-Date Ex-Bonus Ratio
22 Jun 2018 21 Jun 2018 1:1
27 Jun 2013 26 Jun 2013 1:2
30 Mar 2004 26 Mar 2004 1:1
Ex-Date Old FV NEW FV Record Date
21 Jul 2010 2.0 1.0 23 Jul 2010
16 Feb 2004 10.0 2.0 24 Feb 2004

Dividend date Dividend amount Dividend type Record date Instrument type
10 Feb 2026 6.0 Interim 2 10 Feb 2026 Equity shares
14 Nov 2025 4.0 Interim 1 14 Nov 2025 Equity shares
22 May 2025 2.0 Special 22 May 2025 Equity shares
04 Feb 2025 4.0 Interim 2 04 Feb 2025 Equity shares
18 Nov 2024 4.0 Interim 1 18 Nov 2024 Equity shares
16 Feb 2024 4.0 Interim 2 19 Feb 2024 Equity shares
15 Nov 2023 4.0 Interim 1 15 Nov 2023 Equity shares
13 Feb 2023 4.0 Interim 2 13 Feb 2023 Equity shares
18 Nov 2022 4.0 Interim 21 Nov 2022 Equity shares
10 Feb 2022 4.0 Interim 2 11 Feb 2022 Equity shares
08 Nov 2021 4.0 Interim 09 Nov 2021 Equity shares
04 Feb 2021 4.0 Interim 2 05 Feb 2021 Equity shares
12 Nov 2020 4.0 Interim 13 Nov 2020 Equity shares
26 Mar 2020 2.0 Interim 2 27 Mar 2020 Equity shares
14 Nov 2019 2.0 Interim 15 Nov 2019 Equity shares
31 Jul 2019 4.0 Final 02 Aug 2019 Equity shares
21 Jun 2018 7.0 Final 22 Jun 2018 Equity shares
26 Jul 2017 5.25 Final 28 Jul 2017 Equity shares
14 Mar 2017 1.75 Interim 15 Mar 2017 Equity shares
26 Jul 2016 7.0 Final 28 Jul 2016 Equity shares
28 Jul 2015 3.0 Final 30 Jul 2015 Equity shares
01 Aug 2014 4.0 Interim 22 Sep 2014 Equity shares
01 Aug 2014 4.0 Final 05 Aug 2014 Equity shares
24 Jan 2014 3.0 Interim 27 Jan 2014 Equity shares
26 Jun 2013 8.0 Final 27 Jun 2013 Equity shares
02 Aug 2012 4.0 Special 04 Aug 2012 Equity shares
02 Aug 2012 4.0 Final 04 Aug 2012 Equity shares
05 Aug 2011 3.5 Final 09 Aug 2011 Equity shares
21 Jul 2010 3.0 Final 23 Jul 2010 Equity shares
22 Dec 2009 4.5 Final 24 Dec 2009 Equity shares
18 Aug 2008 4.5 Final 21 Aug 2008 Equity shares
20 Sep 2007 1.0 Final 22 Sep 2007 Equity shares
22 Mar 2007 1.0 Special 23 Mar 2007 Equity shares
22 Mar 2007 2.0 Interim 23 Mar 2007 Equity shares
18 Aug 2005 0.0 Final 20 Aug 2005 Equity shares
Ex-Date Ex-Bonus Ratio
22 Jun 2018 21 Jun 2018 1:1
27 Jun 2013 26 Jun 2013 1:2
30 Mar 2004 26 Mar 2004 1:1
Ex-Date Old FV NEW FV Record Date
21 Jul 2010 2.0 1.0 23 Jul 2010
16 Feb 2004 10.0 2.0 24 Feb 2004

Top Gainers

up-arrow (%)

Emami Share Price

Emami Limited was incorporated on March 11, 1983 with the name 'AMP Udyog Viniyog Limited'. Initially, R S Agarwal and R S Goenka set up a cosmetic manufacturing unit at Kolkata in 1974 as 'Kemco Chemicals', a partnership Firm. The cosmetic products, as well as Ayurvedic medicines, manufactured by the unit were marketed under the brand name of Emami. In the year 1978, Himani Ltd, a sick unit, was taken over by the Group and the new management decided to produce different types of health care items and toiletries with Ayurvedic preparation.

In the year 1994, Himani Limited was then merged with AMP Udyog Viniyog Limited and the name was changed to Himani Limited with effect from May 5, 1994. In the year 1995, Kemco Chemicals, the partnership firm was converted into a public limited company under the name and style of Emami Limited with effect from April 1, 1995. In the year 1998, Emami Limited was then merged with Himani Limited and the name was changed to Emami Limited with effect from September 1, 1998.

Emami Limited is one of India's leading FMCG companies engaged in manufacturing & marketing of personal care & healthcare products. Emami is the flagship company of the diversified Emami Group. The company sells over 300 diverse products. Emami's portfolio includes brands like Navratna, BoroPlus, Fair & Handsome, Zandu Balm, Kesh King, Zandu Pancharishta, & Mentho Plus Balm, Dermicool and others.

The company's product categories consists hair care, skin creams, soaps and lotions, talcum powder and ayurvedic healthcare products. Their product portfolio includes Navratna Oil, Boroplus Antiseptic Cream, Fair and Handsome, Navratna Cool Talc, Sona Chandi Chyawanprash, Zandu Balm, Himani Fast Relief, Emami Healthy & Fair, Emami Malai Kesar Cold Cream, Lalima, Sardi Ja and Zandu Pancharishta.

Emami products are available in over 9.4 lac retail outlets across India through its network of 3,150 distributors and its global footprint spans over 60 countries including GCC, Europe, Africa, CIS countries & the SAARC.

Emami has 8 manufacturing units across India. The company has ultra modern manufacturing facilities at Kolkata (West Bengal), Guwahati (Assam), Pantnagar (Uttarakhand), Vapi (Gujarat), Silvassa (Dadra & Nagar Haveli) and Talasari (Maharashtra). They have adopted the Total Quality Management system and all their manufacturing facilities have received cGMP and ISO 9001:2000 certifications. The company has 1 overseas unit in Bangladesh.

In the year 2000, the company's investment undertaking was de-merged into Pan Emami Cosmed Ltd with a view to concentrate on their core FMCG business. In the year 2003, the company set up a new unit at Amingaon, Guwahati. Also, they obtained the certificate of Good Manufacturing Practices for its Pondicherry Units.

During the year 2005-06, the company started a third party manufacturing unit in Baddi in Himachal Pradesh. They set up a wholly owned subsidiary company, namely Emami International FZE, in UAE, to expand their foreign market. In response to the marketplace reality, the company launched 'Navratna' cool talc, an extension of its hugely popular 'cool' oil brand

During the year 2006-07, the company launched Fair and Handsome Fairness Cream for men, Fair & Ageless Fairness Cream, Boroplus Antiseptic Light Cream and Body Lotion and Mr. Black and Mrs. Black, herbal Hair Dye Powder and Malai Kesar Cold Cream in the personal care segment. Also, they launched Sona Chandi Healthy and Fair Baby Massage Oil, Good Morning, an Ayurvedic laxative Churna, Sardi Ja, a cough syrup and Vaporub and Memo-plus, a memory booster, Sanjeevan Dhara - a digestive in the market.

During the year, as per the scheme of amalgamation, JB Marketing & Finance Ltd, the erstwhile marketing company of the Emami Group was amalgamated with the company. The equity shares of the company were listed on the National Stock Exchange Ltd. In May 2007, the company formed a wholly owned subsidiary company namely, Emami Realty Pvt Ltd. The company ventured into the realty business through this wholly owned subsidiary company.

In November 2008, the company acquired 68.9% stake in Zandu Pharmaceutical Works Ltd at a consideration of Rs 713 crore and de-merged Zandu's FMCG business into the company. Simultaneously, real estate undertaking of the company comprising of their interest into Emami Realty Ltd and Zandu's non-core business comprising real estate was de-merged into Emami Infrastructure Ltd with effect from November 05, 2008.

During the year 2009-10, the company launched new products namely, Boroplus Winter Lotion and Emami Malai Kesar Soap in the market. Also, they launched new product variants, Navratna Oil. They introduced Zandu Balm in a new bicolour plastic container. They opened a new depot in Coimbatore to widen South India sales. Also, they commenced operations in Bangladesh.

In 2010, the company's net sales crossed of Rs 1000 crore milestone. During the year, the company carried out a stock split from Rs 2 to Re 1 per share.

During 2011-12, the company increased its direct rural reach. The direct retail coverage increased to 5 lac outlets. During the year, the company initiated Bangladesh and Egypt units which are expected to become operational in 2012-13. During the year, the company upgraded the ayurvedic manufacturing facility at the BT Road unit as per WHO guidelines. The company also completed capacity expansion at its Pantnagar unit. During the year, the company completed integration of the southern distribution channel of Zandu with Emami. The company also enhanced focus on the marketing activities of healthcare products of Zandu.

During 2012-13, the company fortified its direct rural reach across 600,000 outlets. During the year, the company's Bangladesh unit became operational. In 2013, the company launched BoroPlus Face wash.

During 2013-14, the company expanded capacity at its Pantnagar and Amingaon facilities. The Vapi plant was revamped to match the WHO-GMP standards. During the year, the company increased direct retail presence among 625,000 retailers. During the year, both the Research & Innovation (R&I) centres at Kolkata and Mumbai facility became fully operational. On the overseas front, Emami started manufacturing oil at its Bangladesh plant during the year.

In 2014, the company entered the male deodorants space with its brand HE. It also launched Fair & Handsome- Instant Fairness Face wash. Also during the year, the company acquired 'She Comfort' brand of sanitary napkin from Mumbai-based Royal Hygiene Care, marking its foray into the feminine hygiene space.

During 2014-15, Emami undertook capacity expansion initiatives across various units for various products. The company augmented Navratna Oil, BoroPlus Lotion and Vasocare Petroleum Jelly capacities at its Abhoypur plant and enhanced Pancharishtha capacity by 17% at its Vapi unit. During the year, the company started manufacturing Navratna Oil at its Dongari manufacturing plant to cater to export requirements. During the year, Emami initiated setting up a new manufacturing unit under the North-East mega project scheme which is expected to commence operations in FY 2016. The company launched 4 new products during the year. During the year, Emami acquired Fravin Pty Ltd, an Australian organic personal care product major with proven expertise in the realm of R&D, to gain a strong foothold in the highly regulated Australian market.

In June 2015, the company acquired Ayurvedic Hair & scalp business of 'Kesh King' at Rs 1684 crore (including duties & taxes). It also acquired controlling stake in Fravin Pty Ltd.

During 2015-16, Emami invested Rs 150 crore to build a new plant in Assam, which is expected to commence operations by FY 2017. The planned total outlay for the unit is Rs 300 crore. During the year, the company increased direct retail reach to more than 6.4 lac outlets and direct coverage to 13,300 villages with a population less than 50,000.

On 25 January 2016, Zandu Ayurveda, from the house of Emami Limited, announced the launch of Zandu Pure Honey without added sugar in the Indian market.

On 8 August 2016, Emami announced the reintroduction of its pain solution balm Zandu Balm with a new and advanced formulation offering a more effective and faster pain solution.

Emami's 3rd manufacturing unit at Pacharia, Assam was formally inaugurated on 14 November 2017. Located at Pacharia in the Kamrup district of Assam and spread over 34 acres of land, the new plant of the company is the largest production facility of Emami in India. This new facility of Emami Limited is a world-class facility which is designed to spread over a total planned floor area of over 50,000 sq.mt for a total production capacity of 90,000 MTPA. Raw material for the plant will be sourced both from indigenous and overseas locations as per the requirement. Total investment incurred for the new facility is over Rs 300 crore.

On 7 December 2017, Emami announced a strategic investment in Helios Lifestyle Pvt Ltd (Helios) with an acquisition of 30% equity stake for an undisclosed consideration. Helios owns the fast-growing male grooming brand 'The Man Company'. The equity stake will be acquired by 31 December 2018 through infusion of required funds in Helios. 'The Man Company'(TMC) offers a head-to-toe range of premium men's grooming products in Bath & Body, Beard management, Shaving & Perfumes category. The products are currently sold online majorly through the company's own website - www.themancompany.com. All the products are based on premium essential oils and are free of harmful chemicals. The acquisition of stake by Emami is significant as it marks the company's entry in the fast growing online male grooming segment.

On 5 February 2018, Emami Limited announced that it has entered into an agreement for strategic investment in Brillare Science Pvt Ltd (Brillare) through compulsory convertible preference shares (CCPS), which on conversion will result in 26% equity stake in Brillare basis the achievement of agreed future performance of the company. Brillare owns the premium hair & skin care portfolio for use in professional salons. Brillare also provides customised beauty treatment which enables salon professionals to treat multiple hair & skin concerns simultaneously.

During the year 2018-19, the Company acquired a leading personal care products, Creme 21, a German brand. It launched personal and healthcare products like Fair and Handsome 5-in-1 Pimple Clear Instant Fairness Facewash, HE Magic Duo Deodorant, Striveda
Lactation Supplement and Zandu Diabrishta - 21. It also launched variants of HE Deodorants (HE Intense Body Spray), Diamond Shine
Hair Colour (burgundy) and Navratna Smart Cool (Dynamite & Force). It launched the Rahat Raja' television commercial to present Navratna as an antidote beyond the usual to sleeplessness, body ache and the premature greying of hair. It launched HE Magic Duo with a packaging innovation, combining two different fragrances in one bottle. It relaunched Fair & Handsome in innovative packaging. It launched Kesh King Oil with a differentiated special comb applicator to drive equity and consumer convenience.

During year 2019-20, it relaunched key brands like Navratna Cool Talc, Zandu Pancharishta and BoroPlus lotions. It extended Emami's international presence to nearly 60 countries. It integrated the acquired Creme 21 brand into Emami's distribution network. It had 10 subsidiaries as of 31st March, 2020.

During the year 2019-20, Company launched an extension 'Navratna' brand with Navratna Garam Oil to target lapsers in winters, offering solutions for headache, numbness and lethargy. It launched innovative products like Zandu Ayurvedic Cough Syrup, HE Magic Duo and Zandu Anand Balm in the domestic business. For the International markets, it launched new variants of Emami 7 Oils in One
and a Perfect Derma Range under the BoroPlus brand.

In 2020-21, Emami launched BoroPlus Organic Aloe Vera Gel, BoroPlus Hygiene range, EMASOL Home Hygiene range and various healthcare products under Zandu, which mitigates seasonal impact. It localised the supply chain in Bangladesh and contract manufacturing in Germany, Sri Lanka and Dubai, launched the entire range of oils in Bangladesh including Navratna Oil, 7 Oils in One and Kesh King, introduced Creme 21 in Bangladesh, launched health, hygiene and immunity boosting products, introduced localised herbal products while enhancing ayurveda globalisation, in regions like MENA, Bangladesh, Russia, Nepal. The Company introduced more than 50 new products and variants, majorly in the health and hygiene categories during the year. BoroPlus, with its nation-wide strong brand equity for its antiseptic and germ protection properties introduced a personal hygiene range consisting of Hand Sanitizer, Antiseptic Soap, Antiseptic Handwash, Hygiene Liquid and Body wash which received a very encouraging market response. Under the Zandu Healthcare range, the Company introduced Zandu Ayurvedic Sanitizer, Zandu Ortho Vedic Pain relief oil, Zandu
Ayush Kwath Powder, Zandu Single herbs range, Zandu Immu Soft Chews, Zandu Health Juices, Zandu Tulsi and Haldi Drops, among others. It launched a new brand 'EMASOL' which offers a complete range of home hygiene products, with the unique proposition of 24 hr protection. It launched 'Immune India offer' to make Zandu Immunity boosters affordable for Indians and help them boost their immunity. The Company had 8 subsidiaries as of 31 March, 2021.

In March 2022, the Company acquired Dermicool', one of the leading brands in Prickly Heat and Cool Talc Segment from Reckitt Benckiser Healthcare India Pvt. Ltd. costing Rs 432 crore. It acquired a 20.65% equity stake in Tru Native F&B Pvt. Ltd., that markets nutrition products. It increased stake in the associate Company, Helios Lifestyle Pvt. Ltd from 33.09% to 49.53%.

In year 2021-22, Brillare Science Private Limited became a subsidiary of the Company w.e.f. 1st October, 2021.

During 2022-23, Helios Lifestyle Private Limited became a subsidiary of Emami Limited w.e.f 1st July, 2022. Emami International Personal Care Trading LLCUAE, wholly owned subsidiary of the Company incorporated on January 28, 2022 was made the Wholly Owned Subsidiary of Emami international FZE w.e.f. February 15, 2022.

In 2024, Company entered the juice category through a strategic investment in Axiom Ayurveda Pvt Ltd, acquiring a 26% equity stake. It increased the stake in Brillare Science from 82.92% to 100%. It increased the distribution through Project Khoj resulted in an additional coverage of more than 20,000 towns in rural regions since the launch of the project. A cell-based model was developed for assessing wound healing efficacy, optimizing costs, and enabling effective claims for products. For haemorrhoids (piles), Zandu Pileave ointments and
tablets were developed as a comprehensive therapy tool for Ayurvedic practitioners. The Company launched more than 35 new products and variants during the year in the Domestic business, primarily as digital-first launches on its D2C portal, Zanducare. Overall, the Company has introduced more than 90 new product developments on Zanducare since its inception, showcasing a commitment to diversification and innovation.

The Company acquired the balance 70% stake in Helios Lifestyle Pvt Ltd, making it a wholly owned subsidiary in FY 2025. It launched over 25 new products in the domestic business, including 11 on its Direct-toConsumer (D2C) platform, Zanducare in 2025.

Parent organization Emami Group
NSE symbol EMAMILTD
Founded 1983
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow

R S Agarwal

Chairman Emeritus

Sushil K Goenka

Whole Time Director

R S Goenka

Chairman (Non-Executive)

Mohan Goenka

Vice Chairman & Whole time Director

Aditya Vardhan Agarwal

Non Executive Director

Harsh Vardhan Agarwal

Vice Chairman & Managing Director

Priti A Sureka

Whole-time Director

Prashant Goenka

Whole-time Director

C K Dhanuka

Non Executive & Independent Director

Debabrata Sarkar

Non Executive & Independent Director

Anand Nandkishore Rathi

Independent Director

Anjani Kumar Agrawal

Independent Director

Anjan Chatterjee

Independent Director

Avani Davda

Independent Director

Rajiv Khaitan

Lead Independent Director

Mamta Binani

Independent Director

Ravi Varma

Company Sec. & Compli. Officer

Right Arrow

Similar stocks

Left Arrow
similar-logo HINDUNILVR
-1.06%
2135.3 -22.89
down-arrow
similar-logo NESTLEIND
-0.17%
1204.8 -2.09
down-arrow
similar-logo BRITANNIA
0.51%
5887.5 30.00
down-arrow
similar-logo VBL
2.15%
415.1 8.75
down-arrow
similar-logo GODREJCP
1.21%
1053.8 12.70
down-arrow
similar-logo MARICO
0.16%
756 1.25
down-arrow
similar-logo LENSKART
2.01%
511.25 10.10
down-arrow
similar-logo DABUR
-0.16%
451.85 -0.75
down-arrow
similar-logo PATANJALI
0.75%
490.15 3.69
down-arrow
similar-logo COLPAL
0.44%
1941.6 8.69
down-arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Emami Ltd?

Answer Field

Emami Ltd share price is for NSE ₹ 416.85 & for BSE ₹ 417.00 as on Mar 18 2026 03:30 PM.

What is the Market Cap of Emami Ltd Share?

Answer Field

The market cap of Emami Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Mar 18 2026 03:30 PM.

What is the 52 Week High and Low of Emami Ltd?

Answer Field

The 52 Week High and Low of Emami Ltd for NSE is ₹ 653.35 and ₹ 405.05 and for BSE is ₹ 655.40 and ₹ 405.00.

What is 1 year return for Emami Ltd?

Answer Field

The 1 year returns on the stock has been -22.41%.

What is the P/E Ratio of Emami Ltd Share?

Answer Field

As on Mar 18 2026 03:30 PM the price-to-earnings (PE) ratio for Emami Ltd share is 21.39.

What is the PB ratio of Emami Ltd Share?

Answer Field

As on Mar 18 2026 03:30 PM, the price-to-book (PB) ratio for Emami Ltd share is 71.79.

How to Buy Emami Ltd Share?

Answer Field

You can trade in Emami Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Emami Ltd Share on Bajaj Broking App?

Answer Field

To buy Emami Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Emami Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59

Products

arrow

Calculators

arrow

Platforms

arrow

Mutual Funds & SIP

arrow

Important Links

arrow

Explore

arrow

Corporate

arrow

Discover

arrow

Popular Stocks

arrow

Indian Indices

arrow

Global Indices

arrow

Sector Wise Stocks

arrow

IPO

arrow

ATTENTION INVESTORS:

“Investments in securities market are subject to market risk, read all the scheme related documents carefully before investing."

"Prevent Unauthorized transactions in your Trading/Demat Account. Update your mobile numbers/email IDs with your stock brokers/Depository Participant. Receive alerts/information of your transaction/all debit and other important transactions in your Trading/ Demat Account directly from Exchange/CDSL/NSDL at the end of the day. Issued in the interest of investors."

" We collect, retain, and use your contact information for legitimate business purposes only, to contact you and to provide you information & latest updates regarding our products & services."  

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"We understand that certain investment advisors may be approaching members of the public including our clients, representing that they are our partners, or representing that their investment advice is based on our research. Please note that we have not engaged any third parties to render any investment advisory services on our behalf nor are we providing any stock recommendations/tips/research report/advisory. Persons making investments on the basis of such advice may lose all or a part of their investments along with the fee paid to such unscrupulous persons. Please be cautious about any phone call that you may receive from persons representing to be such investment advisors, or a part of research firm offering advice on securities. Do not make payments through e-mail links, WhatsApp or SMS. Please do not share your personal or financial information with any person without proper verification. Always trade through a registered broker."

Bajaj Financial Securities Limited is a subsidiary of Bajaj Finance Limited and is a corporate trading and clearing member of BSE Ltd. and National Stock Exchange of India Ltd. (NSEIL), and also a Depository participant with National Securities Depository Ltd (“NSDL”) and Central Depository Services Ltd. (“CDSL”).

Bajaj Financial Securities Limited is engaged in the business of Stock Broking and as a Depository Participant.Bajaj Financial Securities Limited does not provide any advisory services to its clients. Bajaj Financial Securities Limited may share updates from time to time (through various electronic communication modes) which are sourced from public domain and the same are NOT to be construed as any advice or recommendation from Bajaj Financial Securities Limited. Client is requested to independently evaluate and/or consult their professional advisors before arriving at any conclusion to make any investment. The decision to invest shall be the sole responsibility of the Client and shall not hold Bajaj Financial Securities Limited, its employees and associates responsible for any losses, damages of any type whatsoever.

BSE Ltd. is not in any manner answerable, responsible or liable to any person or persons for any acts of omission or commission, errors, mistakes and/or violation, actual or perceived, by us or our partners, agents, associates etc., of any of the Rules, Regulations, Bye-laws of the Stock Exchange, Mumbai, SEBI Act or any other laws in force from time to time.

BSE Ltd. is not answerable, responsible or liable for any information on this Website or for any services rendered by our employees, our servants, and us.

Personal Loan, Fixed Deposit, EMI Card are provided by Bajaj Finance Limited. Bajaj Financial Securities Limited is only a distributor. These are not exchange traded products and all disputes with respect to the distribution activity, would not have access to exchange investor redressal forum or Arbitration mechanism.

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.

Please Note:

  1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020

  2. Update your mobile number & email ID with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

  3. Pay 20% upfront margin of the transaction value to trade in cash market segment.

  4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 and BSE vide notice no. 20200731-7 dated July 31, 2020 and 20200831-45 dated August 31, 2020 and other guidelines issued from time to time in this regard.

  5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.

Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in Vernacular Language: BSE | NSE

If the client wishes to revoke /cancel the EDIS mandate placed by them, they can write on email us or call on the toll free number.

Advisory for Investors : NSE | BSE

We also do pro-account trading in Equity & Derivatives Segment.

Filling complaints on SCORES - Easy & Quick

A.  Register on SCORES portal B. Mandatory details for filling complaints on SCORES (i) Name, PAN, Address, Mobile Number, E-mail ID C. Benefits: (i) Effective Communication (ii) Speedy redressal of the grievances.

SEBI Registration No.: INZ000218931 | BSE Cash/CDS/F&O (Member ID: 6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No : IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN – 163403 Research Analyst SEBI Registration No. INH000010043

Compliance officer:

Mr. Boudhayan Ghosh 
TEL: 020-48574486
Email for any investor grievances or write to us for DP related matters.

DISCLAIMER

STANDARD DISCLAIMER

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403. 

Website: Bajaj Broking

RESEARCH DISCLAIMER

Broking services offered by Bajaj Financial Securities Limited | Registered Office: Bajaj Auto Limited Complex , Mumbai –Pune Road Akurdi Pune 411035 | Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014 | CIN: U67120PN2010PLC136026 | Research Analyst SEB I Registration No: INH000010043.

Details of Compliance Officer: 

Mr. Boudhayan Ghosh (For Broking/DP/Research)
Email | Contact No.: 020-4857 4486 

Investment in the securities involves risks, investor should consult his own advisors/consultant to determine the merits and risks of investment.

DISCLOSURES

Disclosures under the provisions of SEBI (Research Analysts) Regulations 2014 (Regulations) 

Bajaj Financial Securities Limited ("Bajaj Broking" or "Research Entity") is regulated by the Securities and Exchange Board of India ("SEBI") and is licensed to carry on the business of broking, depository services and related activities. There were no instances of non-compliance by Bajaj Financial Securities Limited on any matter related to the capital markets, resulting in significant and material disciplinary action during the last three years. This research report has been prepared and distributed byBajaj Financial Securities Limited in the capacity of a Research Analyst as per Regulation 22(1) of SEBI (Research Analysts) Regulations 2014 having SEBI Registration No. INH000010043. 

DISCLAIMER

This e-mail/ short message service (SMS) may contain confidential, proprietary or legally privileged information. It should not be used by anyone who is not the original intended recipient. If you have erroneously received this message, please delete it immediately and notify the sender. The recipient acknowledges thatBajaj Financial Securities Limited or its holding and/or associated companies, as the case may be, are unable to exercise control or ensure or guarantee the integrity of/over the contents of the information contained in e-mail /SMS transmissions and further acknowledges that any views expressed in this message are those of the individual sender and no binding nature of the message shall be implied or assumed unless the sender does so expressly with due authority of Bajaj Financial Securities Limited. This message is not intended as an offer or publication or solicitation for distribution for subscription of or purchase or sale of any securities or financial instrument(s) to anyone in whose jurisdiction such subscription etc. requires prior local regulatory clearance or is contrary to the local laws of the land in any manner or as an official confirmation of any transaction. Before opening any attachments, please check them for viruses and defects. 

This service / information is strictly confidential and is being furnished to you solely for your information. This information should not be reproduced or redistributed or passed on directly or indirectly in any form to any other person or published, copied, in whole or in part, for any purpose unless otherwise expressly authorised. This service / information is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subjectBajaj Financial Securities Limited and affiliates/ group/holding companies to any registration or licensing requirements within such jurisdiction. The distribution of this document in certain jurisdictions may be restricted by law, and persons in whose possession this document comes, should inform themselves about and observe any such restrictions.  

The data would be provided to the clients on an "as is" and "where-is" basis, without any warranty. Bajaj Financial Securities Limited or its subsidiaries and associated companies shall not be liable for any delay or any other interruption which may occur in providing the data due to any reason including network (Internet) reasons or snags in the system, breakdown of the system or any other equipment, server breakdown, maintenance shutdown, breakdown of communication services or inability of the Bajaj Financial Securities Limited or its subsidiaries and associated companies to provide the data. In no event shall the Bajaj Financial Securities Limited or its holding and associated companies be liable for any damages, including without limitation direct or indirect, special, incidental, or consequential damages, losses or expenses arising in connection with the data provided by the Bajaj Financial Securities Limited or its holding and associated companies.

ADDITIONAL DISCLAIMER FOR U.S. PERSONS

Bajaj Financial Securities Limited is not a registered broker-dealer under the U.S. Securities Exchange Act of 1934, as amended (the"1934 act") and under applicable state laws in the United States. In addition, Bajaj Financial Securities Limited is not a registered investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the "Acts), and under applicable state laws in the United States. Accordingly, in the absence of specific exemption under the Acts, any brokerage and investment services provided by Bajaj Financial Securities Limited, including the products and services described herein are not available to or intended for U.S. persons. This email message does not constitute an offer or invitation to purchase or subscribe for any securities or solicitation of any investments or investment services and/or shall not be considered as an advertisement tool. "U.S. Persons" are generally defined as a natural person, residing in the United States or any entity organized or incorporated under the laws of the United States. US Citizens living abroad may also be deemed "US Persons" under certain rules.  

ADDITIONAL DISCLAIMER FOR CANADIAN PERSONS

Bajaj Financial Securities Limited is not a registered adviser or dealer under applicable Canadian securities laws nor has it obtained an exemption from the adviser and/or dealer registration requirements under such law. Accordingly, any brokerage and investment services provided by Bajaj Financial Securities Limited, including the products and services described herein are not available to or intended for Canadian persons.  

This mailer and its respective contents do not constitute an offer or invitation to purchase or subscribe for any securities or solicitation of any investments or investment services.  

DISCLAIMER FOR REPORT

DISCLOSURES UNDER THE PROVISIONS OF SEBI (RESEARCH ANALYSTS) REGULATIONS 2014 (REGULATIONS)

Bajaj Financial Securities Limited ("Bajaj Broking" or "Research Entity") is regulated by the Securities and Exchange Board of India ("SEBI") and is licensed to carry on the business of broking, depository services and related activities.  

This Report has been prepared by Bajaj Financial Securities Limited in the capacity of a Research Analyst having SEBI Registration No. INH000010043 and distributed as per SEBI (Research Analysts) Regulations 2014. This report does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. The information contained herein is from publicly available data or other sources believed to be reliable. This report is provided for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this report should make such investigation as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult his own advisors to determine the merits and risks of such investment. The investment discussed or views expressed may not be suitable for all investors.  

This information is strictly confidential and is being furnished to you solely for your information. This information should not be reproduced or redistributed or passed on directly or indirectly in any form to any other person or published, copied, in whole or in part, for any purpose. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject Bajaj Financial Securities Limited and associates / group companies to any registration or licensing requirements within such jurisdiction. The distribution of this report in certain jurisdictions may be restricted by law, and persons in whose possession this report comes, should observe, any such restrictions. The information given in this report is as of the date of this report and there can be no assurance that future results or events will be consistent with this information. This information is subject to change without any prior notice. Bajaj Financial Securities Limited reserves the right to make modifications and alterations to this statement as may be required from time to time. Bajaj Financial Securities Limited or any of its associates / group companies shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. Bajaj Financial Securities Limited is committed to providing independent and transparent recommendation to its clients. Neither Bajaj Financial Securities Limited nor any of its associates, group companies, directors, employees, agents or representatives shall be liable for any damages whether direct, indirect, special or consequential including loss of revenue or lost profits that may arise from or in connection with the use of the information. Our proprietary trading and investment businesses may make investment decisions that are inconsistent with the recommendations expressed herein. Past performance is not necessarily a guide to future performance .The disclosures of interest statements incorporated in this report are provided solely to enhance the transparency and should not be treated as endorsement of the views expressed in the report. The information provided in these reports remains, unless otherwise stated, the copyright of Bajaj Financial Securities Limited. All layout, design, original artwork, concepts and other Intellectual Properties, remains the property and copyright of Bajaj Financial Securities Limited and may not be used in any form or for any purpose whatsoever by any party without the express written permission of the copyright holders.  

We offer our research services to clients as well as our prospects. Though this report is disseminated to all the customers simultaneously, not all customers may receive this report at the same time. We will not treat recipients as customers by virtue of their receiving this report.  

Bajaj Financial Securities Limited and its associates, officer, directors, and employees, research analyst (including relatives) worldwide may: (a) from time to time, have long or short positions in, and buy or sell the securities thereof, of company(ies), mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the subject company/company(ies) discussed herein or act as advisor or lender/borrower to such company(ies) or have other potential/material conflict of interest with respect to any recommendation and related information and opinions at the time of publication of research report or at the time of public appearance. Bajaj Financial Securities Limited may have proprietary long/short position in the above-mentioned scrip(s) and therefore should be considered as interested. The views provided herein are general in nature and do not consider risk appetite or investment objective of any particular investor; readers are requested to take independent professional advice before investing. This should not be construed as invitation or solicitation to do business with Bajaj Financial Securities Limited.  

Bajaj Financial Securities Limited or its associates may have received compensation from the subject company in the past 12 months. Bajaj Financial Securities Limited or its associates may have managed or co-managed public offering of securities for the subject company in the past 12 months. Bajaj Financial Securities Limited or its associates may have received compensation for investment banking or merchant banking or brokerage services from the subject company in the past 12 months. Bajaj Financial Securities Limited or its associates may have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past 12 months. Bajaj Financial Securities Limited or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report. Research analyst or his/her relative or Bajaj Financial Securities Limited’s associates may have financial interest in the subject company. Bajaj Financial Securities Limited, its associates, research analyst and his/her relative may have other potential/material conflict of interest with respect to any recommendation and related information and opinions at the time of publication of research report or at the time of public appearance.  

Research analyst has served as an officer, director or employee of subject Company: No  

Bajaj Financial Securities Limited has financial interest in the subject companies: No  

Bajaj Financial Securities Limited’s Associates may have actual/beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of research report.  

Research analyst or his/her relative has actual/beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of research report: No  

Bajaj Financial Securities Limited has actual/beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of research report: No  

Subject company may have been client during twelve months preceding the date of distribution of the research report.  

There were no instances of non-compliance by Bajaj Financial Securities Limited on any matter related to the capital markets, resulting in significant and material disciplinary action during the last three years. A graph of daily closing prices of the securities is also available at NSE

ANALYST CERTIFICATION

The analyst for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about the subject company or companies and its or their securities, and no part of his or her compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report.  

RISK DISCLOSURE ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

BROKERAGE DISCLAIMER

All leveraged intraday positions will be squared off on the same day. There is no restriction on the withdrawal of the unutilised margin amount. Brokerage will not exceed the SEBI prescribed limit. Visit : Pricing

MTF 

As subject to the provisions of SEBI Circular CIR/MRD/DP/54/2017 dated June 13, 2017, and the terms and conditions mentioned in the lights and obligations statement issued by the TM (if applicable).  

US INVESTING

International investment is not supervised by any regulatory body in India. Thus, any claim or dispute relating to such investment or enforcement of any agreement/contract /claim will not be under laws and regulations of the recognized stock exchanges and investor protection under Indian Securities Law. The account opening process will be carried out on Vested platform and Bajaj Financial Securities Limited will not have any role in it.  

IPO 

This should not be construed as soliciting investment. Investors’ discretion is required. Kindly consult your financial expert before investing. No need to issue cheques by investors while subscribing to IPO. Investments in securities markets are subject to market risks, read all the related documents carefully before investing.  

SCREENERS 

Screeners is not Exchange-approved products and any disputes related to the same will not be dealt on the Exchange platform. 

SECURITIES 

Securities quoted are exemplary and not recommendatory. 

IPV 

Account would be open after all procedure relating to IPV and client due diligence is completed. 

IMAGES 

The images used are only for representation purpose. Proper due diligence has been done for the images and the image is not of any artist. The same is captured from royalty free sites.

THIRD PARTY PRODUCT DISCLAIMER

Bajaj Financial Securities Limited is a distributor for Non-Broking Products/Services such as Mutual Funds, Mutual Funds SIP, IPO, Bonds, Insurance, PMS, Global Investing, any other third-party products/services. These are not Exchange Traded Products, and we are only acting as distributors. All disputes with respect to the distribution activity, would not have access to SCORES/ODR, Exchange investor redressal forum or Arbitration mechanism. Please refer to the detailed disclaimer for Third-Party Products.

DISCLOSURE TO CLIENTS REGARDING PAYOUT OF FUNDS

As per SEBI circular no. SEBI/HO/MIRSD/MIRSD-PoD-1/P/CIR/2023/84 dated June 08, 2023, Stockbrokers are required to upstream the entire client funds lying with them to the Clearing Corporation. Based on client’s request the funds’ release request must be placed with the Clearing Corporation. Based on the internal process and cut-off timelines of the Clearing Corporation the funds will be released to the Stock Broker. In view of this new process, as specified by the regulatory and the cut-off time of Clearing Corporation/Banks processing the funds, Bajaj Financial Securities Limited cannot commit the exact time for releasing funds payout to its client. Clients are requested to note that, Bajaj Financial Securities Limited will not be responsible for any inconvenience caused to clients due to delay in release of funds payout, including fines, delayed charges, defaults, etc.